Research
October 19, 2026
Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney disease.
February 25, 2026
February 23, 2026
February 13, 2026
February 11, 2026
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community